| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/14/1999 | EP0550661B1 Uses of gro genes and proteins |
| 04/14/1999 | EP0548200B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 04/14/1999 | CN1213972A Contrast agent and improved contrast agent thereof |
| 04/14/1999 | CN1213971A Thermally stabilized contrast agent |
| 04/08/1999 | WO1999016881A1 Antigen protein and nucleic acid coding for said protein |
| 04/08/1999 | WO1999016757A1 Contrasting agent for infarct and necrosis imaging |
| 04/08/1999 | WO1999016474A1 Lipophilic metal complexes for necrosis and infarct imaging |
| 04/08/1999 | WO1999016467A1 Non-anaphylactic forms of allergens and their use |
| 04/08/1999 | WO1999016422A1 Stabilized preparations for use in metered dose inhalers |
| 04/08/1999 | WO1999016421A1 Stabilized bioactive preparations and methods of use |
| 04/08/1999 | WO1999016420A1 Stabilized preparations for use in nebulizers |
| 04/08/1999 | WO1999016419A1 Perforated microparticles and methods of use |
| 04/08/1999 | WO1999005521A3 Conjugate for differentiating between healthy and unhealthy tissue |
| 04/08/1999 | WO1998055103A9 Anti-tumoral therapy agent |
| 04/08/1999 | WO1998049314A8 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
| 04/08/1999 | CA2304458A1 Contrasting agent for infarct and necrosis imaging |
| 04/07/1999 | EP0906571A1 Labelling and selection of molecules |
| 04/07/1999 | EP0854716A4 Androgenic directed compositions |
| 04/07/1999 | EP0782565B1 Iodinated x-ray-contrast media |
| 04/07/1999 | EP0717737B1 Chelants as contrast enhancing agents |
| 04/07/1999 | CN1042794C Improved emulsions of highly fluorinated organic compounds |
| 04/06/1999 | US5891857 Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
| 04/06/1999 | US5891341 Compositions and devices for partitioning advanced glycosylation endproducts, and methods of their use |
| 04/06/1999 | CA2163086C Magnetic resonance imaging agent containing barium sulfate and a clay |
| 04/06/1999 | CA1340483C Diagnosis of retinoblastoma |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015626A1 Identification of hop-1 and uses thereof |
| 04/01/1999 | WO1999015541A2 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside |
| 04/01/1999 | WO1999015540A2 Method for producing a pentopyranosyl nucleoside |
| 04/01/1999 | WO1999015539A2 Pentopyranosyl nucleoside, and production and use of the same |
| 04/01/1999 | WO1999015204A1 Method for determining oncogenic activity of a substance |
| 04/01/1999 | WO1999002120A3 Compositions and methods for reversibly increasing permeability of biomembranes |
| 04/01/1999 | WO1998057665A3 The use of mononuclear phagocytes in in vivo imaging of hypoxic/ischaemic tissue |
| 04/01/1999 | WO1998054301A3 Transplants for myocardial scars and method and cellular preparations therefor |
| 04/01/1999 | WO1998053856A9 Methods for the detection, treatment, and prevention of neurodegeneration |
| 04/01/1999 | WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/01/1999 | CA2304129A1 Tie ligand homologues |
| 04/01/1999 | CA2303784A1 Use of a pentopyranosylnucleoside for the production of an electronic component, and conjugates thereof |
| 04/01/1999 | CA2302414A1 Process for the preparation of a pentopyranosylnucleoside |
| 03/31/1999 | EP0905135A2 Cocaine receptor binding ligands |
| 03/31/1999 | EP0904349A1 Transgenic non-human mammals with progressive neurologic disease |
| 03/31/1999 | EP0904292A1 Growth differentiation factor-14 |
| 03/31/1999 | EP0904264A1 Compositions for increasing the mri contrast in visualising the digestive tract of patients |
| 03/31/1999 | EP0904113A2 Microencapsulated fluorinated gases for use as imaging agents |
| 03/31/1999 | EP0567514B1 A system for enhanced in-vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion of agents |
| 03/31/1999 | CN1212629A Contrast media |
| 03/31/1999 | CN1042700C Dextran albumin acoustical contrast medium containing perfluocarbon or sulfur hexafluoride and its producing method |
| 03/30/1999 | US5889143 Evaluation and treatment of patients with progressive immunosuppression |
| 03/30/1999 | US5888997 Radiation sensitization using texaphyrins |
| 03/30/1999 | US5888816 Cell cultures of and cell culturing method for nontransformed pancreatic, thyroid, and parathyroid cells |
| 03/30/1999 | US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore |
| 03/30/1999 | US5888498 Cellular and animal models for diseases associated with mitochondrial defects |
| 03/30/1999 | US5888476 Magnetic resonance blood pool agents |
| 03/25/1999 | WO1999014355A2 Highly affine nucleic acid molecules, production and application of same |
| 03/25/1999 | WO1999013919A1 Novel targeted contrast agents for diagnostic and therapeutic use |
| 03/25/1999 | WO1999013918A2 Icam-1 selective echogenic microbubbles |
| 03/25/1999 | WO1999013917A1 Methods and kits for identifying ductal orifices in a nipple |
| 03/25/1999 | WO1999013916A2 Methods and compositions for medical imaging |
| 03/25/1999 | WO1999007325A8 Liver function test |
| 03/25/1999 | DE19741715A1 New pentopyranosyl nucleoside compounds |
| 03/25/1999 | DE19741084A1 New library of chemically modified nucleic acid molecules |
| 03/24/1999 | EP0903408A2 Tat-derived transport polypeptide |
| 03/24/1999 | EP0902686A2 A process for the purification of opacifying contrast agents |
| 03/24/1999 | CN1211929A Process for purification of opacifying contrast agents |
| 03/23/1999 | US5886179 Nucleotide analogs |
| 03/23/1999 | US5886173 Metallation of macrocycles with 2,4-dicarbonyl-metal complexes |
| 03/23/1999 | US5886169 Iodinated polymers, processes for preparing them and their applications as contrast media |
| 03/23/1999 | US5886158 Gadolium complexes of branched derivatives of gadoteric acid; contrast agents for magnetic resonance imaging, conventional radiology and dichromaography; quality images with low concentration; side effect reduction |
| 03/23/1999 | US5885550 Ophthalmic whitening solution |
| 03/23/1999 | US5885549 Trimers, oligomers and polymers of an alicyclic polyphosphate e.g. inositol hexaphophate, complexed with a paramagnetic metal ion; low metal absorption; low dosage; tumors |
| 03/23/1999 | US5885548 Diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 for use as contrast media and antidotes |
| 03/23/1999 | US5885211 Microporation of human skin for monitoring the concentration of an analyte |
| 03/18/1999 | WO1999012974A1 Monoclonal antibodies that bind testosterone |
| 03/18/1999 | WO1999012640A1 Coated particles, methods of making and using |
| 03/18/1999 | WO1999012578A1 Radiation dosimetry with magnetic resonance detectable compounds |
| 03/18/1999 | WO1999012577A1 Polymer particles made of polyvinyl alcohol and comprising a contrast agent for chemoembolization |
| 03/18/1999 | WO1998059005A3 Use of polycarbonates containing iodine phenyl carbonate for producing special shaped parts |
| 03/18/1999 | CA2300804A1 Monoclonal antibodies that bind testosterone |
| 03/17/1999 | EP0901793A1 Thermal preactivation of gaseous precursor filled compositions |
| 03/17/1999 | EP0901496A1 Contrast agents |
| 03/17/1999 | EP0901491A1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters |
| 03/17/1999 | EP0901460A1 A process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid derivatives |
| 03/16/1999 | US5883246 Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds |
| 03/16/1999 | US5882654 Polyvalent melanoma vaccine |
| 03/16/1999 | US5882628 Contrast media |
| 03/16/1999 | US5882627 Methods and compositions for in-vivo detection of oral cancers precancerous conditions |
| 03/16/1999 | US5882626 Therapy for killing tumor cells using antibodies |
| 03/16/1999 | US5882330 Drugs and methods for treating diseases |
| 03/16/1999 | CA2141534C Artifact-free imaging contrast agent |
| 03/11/1999 | WO1999011604A1 Sterilized 5-aminolevulinic acid |
| 03/11/1999 | WO1999011294A1 Stable radioiodine conjugates and methods for their synthesis |
| 03/11/1999 | DE19740403A1 New tri:iodo-phenyl compounds used in diagnosis and therapy |
| 03/10/1999 | EP0900804A2 Analogs for specific oligosaccharide-protein interactions and uses therefor |
| 03/10/1999 | EP0505357B1 Method for antibody targeting of diagnostic or therapeutic agents |
| 03/09/1999 | US5880326 Models for measuring the sense of smell |
| 03/09/1999 | US5880287 Polyoxyhydrocarbyl related products and methods for fluorescence assays |
| 03/09/1999 | US5879662 Oral echo contrast medium for ultrasonic diagnosis |
| 03/09/1999 | US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 03/04/1999 | WO1999010744A1 Diagnostic kit for skin tests, and method |